Skip to content

Evaluation of Rheumatic disease by Nailfold Videocapillaroscope, flowcytometer, Autoantibody mesurement, Dermatohistopathology

Evaluation of Rheumatic disease by Nailfold Videocapillaroscope, flowcytometer, Autoantibody mesurement, Dermatohistopathology - SCOPE study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000014293
Enrollment
200
Registered
2014-06-17
Start date
2014-06-30
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic Sclerosis, polymyositis/dermatomyositis, Mixed Connective Tissue Disease. Systemic lupus erythematosus

Interventions

None listed

Sponsors

University of Occupational and Environmental Health, Japan
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who give a full consent to this study

Exclusion criteria

Exclusion criteria: Patients who are inadequate by investigator's decision

Design outcomes

Primary

MeasureTime frame
Relationship between the semiquantitative nailfold videocapillaroscopy assessment and the severity score of rheumatic disease

Secondary

MeasureTime frame
Relationship among the semiquantitative nailfold videocapillaroscopy assessment, the specific autoantibody, the dermatohistopathology, the score of interstitial pneumonia, the pressure of pulmonary artery, and the patients background.

Countries

Japan

Contacts

Public ContactYoshiya Tanaka

University of Occupational and Environmental Health, Japan The first department of internal medicine, school of medicine

tanaka@med.uoeh-u.ac.jp093-603-1611

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026